PPAR-delta and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism

Meric A. Altinoz*, Aysel Ozpinar

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)245-256
Number of pages12
JournalInternational Immunopharmacology
Volume69
DOIs
Publication statusPublished - Apr 2019

Keywords

  • Erucic acid
  • PPAR-delta
  • Multiple sclerosis
  • Alzheimer's Disease
  • Neuroprotection
  • Remyelination
  • PROLIFERATOR-ACTIVATED RECEPTOR
  • CENTRAL-NERVOUS-SYSTEM
  • X-LINKED ADRENOLEUKODYSTROPHY
  • LORENZOS OIL
  • COGNITIVE IMPAIRMENT
  • BRASSICA-JUNCEA
  • CELLS
  • BRAIN
  • EXPRESSION
  • MACROPHAGES

Cite this